Web Exclusives

Cancer survivors need not be excluded from advanced stage lung cancer trials

A previous history of cancer cancer did not impact clinical outcomes in advanced lung cancer patients and these patients therefore should be considered for inclusion in clinical trials, according to a study .

ASTRO applauds CMS decision to cover annual screening for high-risk lung cancer patients

The American Society for Radiation Oncology (ASTRO) has signaled their approval of the decision by the Centers for Medicare and Medicaid Services to provide coverage for annual lung cancer screening for those at very high risk for lung cancer.

Additional PET/CT scans have value in follow-up of lung cancer patients

Research indicates a high value of scans that could lead to future change of reimbursement policies for follow-up PET/CT studies in lung cancer.

Two major studies strengthen case for prostate cancer drug before chemotherapy

The pioneering prostate cancer drug abiraterone can significantly extend the lives of men with advanced prostate cancer if administered prior to administering chemotherapy, according to phase III clinical trial data.

Study may support active surveillance for favorable intermediate-risk prostate cancer

New research suggests that active surveillance may be an initial approach for men with favorable intermediate-risk prostate cancer.

Most commonly used treatment for prostate cancer is radiotherapy

A recent study has determined that radiation therapy is the most common treatment for prostate cancer regardless of cancer stage, PSA level, or prognosis and risk rating.

Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.

New opportunity to treat drug-resistant leukemia discovered

New opportunity to treat drug-resistant leukemia discovered

A previously unrecognized action as a potent inhibitor of the dominant mutation that confers drug resistance to all well-tolerated treatments in patients with certain leukemia types has been found in Axitinib.

Major study links two new genetic variants to breast cancer

A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer.

Potential treatment for pancreatic cancer could increase life expectancy

Researchers have developed a device that uses electric fields to drive chemotherapy drugs through the protective barrier of tissue and directly into pancreatic tumors, preventing their growth.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs